CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Blood

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2007-01-069781PMID 17384200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Graft-versus-host disease

  2007cited by this paper
• Polymorphisms within the CTLA4 gene are associated with infant atopic dermatitis

  2006cited by this paper
• Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer.

  2006cited by this paper
• A molecular perspective of CTLA-4 function.

  2006cited by this paper
• Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia

  2005cited by this paper
• Costimulation blockade with belatacept in renal transplantation.

  2005cited by this paper
• The B7 family revisited.

  2005cited by this paper
• Beyond the HLA typing age: genetic polymorphisms predicting transplant outcome.

  2005cited by this paper
• CTLA4/CT60 polymorphism is not relevant in susceptibility to autoimmune inflammatory intestinal disorders.

  2005cited by this paper
• Journal of Autoimmune Diseases BioMed Central

  2005cited by this paper
• Costimulation blockade with belatacept in renal transplantation.

  2005cited by this paper
• Molecules and mechanisms of the graft-versus-leukaemia effect

  2004cited by this paper
• CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States

  2004cited by this paper
• Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity

  2004cited by this paper
• Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus.

  2004cited by this paper
• Minor histocompatibility antigens--big in tumour therapy.

  2004cited by this paper
• Genetic polymorphisms predicting the outcome of bone marrow transplants

  2004cited by this paper
• Cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) gene polymorphism and susceptibility to non‐Hodgkin's lymphoma

  2004cited by this paper
• CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease

  2003cited by this paper
• T cell anergy.

  2003cited by this paper
• Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

  2003cited by this paper
• The control of T cell activation vs. tolerance.

  2003cited by this paper
• Immunobiology of acute graft-versus-host disease.

  2003cited by this paper
• Increased Expression of Soluble Cytotoxic T‐Lymphocyte‐Associated Antigen‐4 Molecule in Patients with Systemic Lupus Erythematosus

  2003cited by this paper
• CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region

  2002cited by this paper
• The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.

  2002cited by this paper
• Cutting Edge: A Soluble Form of CTLA-4 in Patients with Autoimmune Thyroid Disease

  2000cited by this paper
• CTLA-4 Gene Polymorphism at Position 49 in Exon 1 Reduces the Inhibitory Function of CTLA-4 and Contributes to the Pathogenesis of Graves’ Disease1

  2000cited by this paper
• A native soluble form of CTLA-4.

  2000cited by this paper
• CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis.

  1999cited by this paper
• The A-G polymorphism in exon 1 of theCTLA-4 gene is not associated with systemic lupus erythematosus

  1999cited by this paper
• A soluble form of CTLA‐4 generated by alternative splicing is expressed by nonstimulated human T cells

  1999cited by this paper
• Transplantation of anergic histoincompatible bone marrow allografts.

  1999cited by this paper
• CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.

  1997cited by this paper
• Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.

  1996cited by this paper
• CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

  1996cited by this paper
• 1994 Consensus Conference on Acute GVHD Grading.

  1995cited by this paper
• Graft-versus-host disease.

  1991cited by this paper
• Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

  1979cited by this paper

• Higher relapse and worse overall survival in recipients with CTLA-4 AA genotype of rs231775 following single-unit cord blood transplantation in adults

  2024cites this paper
• Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma

  2024cites this paper
• Immune Checkpoints in Solid Organ Transplantation

  2023cites this paper
• Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma

  2023cites this paper
• Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients

  2023cites this paper
• Are the Costimulatory Molecule Gene Polymorphisms (CTLA-4) Associated With Infection in Organ Transplantation? A Meta-Analysis

  2023cites this paper
• LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors

  2023cites this paper
• The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies

  2022cites this paper
• Association of cytotoxic T-lymphocyte antigen-4 (CTLA-4) single nucleotide polymorphism in donors with clinical outcome after allogeneic hematopoietic stem cell transplantation: a meta-analysis

  2021influential citation
• The Role of CTLA4 and Its Polymorphisms in Solid Organ and Haematopoietic Stem Cell Transplantation

  2021influential citation
• Analysis of CTLA-4 -318C/T Polymorphism in Thalassemia Patients Transfused at the Casablanca Children's Hospital (Morocco)

  2021cites this paper
• Association of Polymorphisms in T-Cell Activation Costimulatory/Inhibitory Signal Genes With Allograft Kidney Rejection Risk

  2021cites this paper
• Genetic Polymorphisms of Cytotoxic T‐Lymphocyte Antigen 4 (CTLA‐4) and clinical outcomes post‐allogeneic hematopoietic stem cell transplantation: A systematic review and meta‐analysis

  2021influential citation
• Analysis of Relationships between Immune Checkpoint and Methylase Gene Polymorphisms and Outcomes after Unrelated Bone Marrow Transplantation

  2021cites this paper
• Einfluss von CTLA-4 Polymorphismen auf die Rezidivrate, die transplantations-assoziierte Letalität und das Überleben nach allogener hämatopoetischer Stammzelltransplantation im Kindesalter

  2020cites this paper
• Umbilical cord blood transplantation and the impact of the CTLA4 genotype on outcomes

  2019cites this paper
• T细胞耗竭在诱导免疫耐受、预防移植物抗宿主病中的作用

  2019cites this paper
• CTLA‐4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood

  2019cites this paper
• Genetic Polymorphism in Cytokines and Costimulatory Molecules in Stem Cell and Solid Organ Transplantation.

  2019cites this paper
• Association of CTLA4 Gene Polymorphism with Transfusion Reaction after Infusion of Leukoreduced Blood Component

  2019cites this paper
• Effect of CTLA4 gene polymorphism on relapse probability among patients with acute leukemias after allogenic hematopoietic stem cells transplantation

  2019cites this paper
• Investigating the genetics ofcord blood transplantation:from classical and non-classical HLAtowards non-HLA genetics and more

  2018cites this paper
• CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens

  2018cites this paper
• IMPACT OF CTLA-4 AND NOD2/CARD15 GENE VARIATIONS ON GRAFT- VERSUS-HOST DISEASE AFTER ALLOGENEIC HSCT: A STRUCTURED REVIEW

  2018influential citation
• The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation

  2018cites this paper
• PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation

  2018cites this paper
• From genetic single candidate gene studies to complex genomics of GvHD

  2017cites this paper
• Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches.

  2017cites this paper
• Impact of CTLA4 genotype and other immune response gene polymorphisms on outcomes after single umbilical cord blood transplantation.

  2017cites this paper
• In Vitro Cell Expansion and CTLA4 in Advanced T-Cell Therapies

  2017cites this paper
• Cytotoxic T-lymphocyte Associated Antigen-4 (CTLA-4) Polymorphism, Cancer, and Autoimmune Diseases

  2017cites this paper
• Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant.

  2017cites this paper
• Relationship of CTLA4 and CD28 polymorphisms with lung involvement, HRCT findings and pulmonary function tests in Turkish patients with ankylosing spondylitis

  2017cites this paper
• Genetic predisposition of acute graft-versus-host disease after hematopoietic stem cell transplantation from an HLA-identical sibling donor

  2016cites this paper
• Antígens menors d'histocompatibilitat en el trasplantament al·logènic de progenitors hematopoètics. Modulació de la resposta en funció del genotip CTLA-4

  2016influential citation
• Pharmacogenomics and the treatment of acute myeloid leukemia.

  2016cites this paper
• The Association Between Viral Infections and Co-stimulatory Gene Polymorphisms in Kidney Transplant Outcomes

  2016cites this paper
• CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation

  2016cites this paper
• CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor

  2016influential citation
• Cytotoxic T Lymphocyte Antigen-4 Down-Regulates T Helper 1 Cells by Increasing Expression of Signal Transducer and Activator of Transcription 3 in Acute Graft-versus-Host Disease.

  2016cites this paper
• Association between the cytotoxic T-lymphocyte antigen-4 mutations and the susceptibility to systemic lupus erythematosus; Contribution markers of inflammation and oxidative stress.

  2016influential citation
• Polymorphisms of the Costimulatory Genes CTLA-4, CD28, PD-1, and ICOS and Outcome of Kidney Transplants in Iranian Patients.

  2016cites this paper
• CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease

  2016cites this paper
• Analysis of a Genetic Polymorphism in the Costimulatory Molecule TNFSF4 with Hematopoietic Stem Cell Transplant Outcomes.

  2016cites this paper
• Non‐HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome?

  2015cites this paper
• CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.

  2015cites this paper
• Identification and Utilization of Donor and Recipient Genetic Variants to Predict Survival After HCT: Are We Ready for Primetime?

  2015cites this paper
• A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation

  2015cites this paper
• Pretransplantation fluorine-18-deoxyglucose--positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation.

  2014cites this paper
• Découverte de nouveaux marqueurs pharmacogénomiques de la maladie du greffon contre l'hôte en transplantation de cellules souches hématopoïétiques

  2014cites this paper
• Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis.

  2014cites this paper
• Polymorphism of costimulatory molecules (CTLA4, ICOS, PD.1 and CD28) and allogeneic hematopoietic stem cell transplantation in Iranian patients

  2014influential citation
• Association between cytotoxic T lymphocyte antigen-4 +49A/G, −1722T/C, and −1661A/G polymorphisms and cancer risk: a meta-analysis

  2014cites this paper
• CTLA-4 polymorphism and clinical outcome post allogeneic hematopoietic stem cell transplantation.

  2013cites this paper
• CTLA-4 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease.

  2013cites this paper
• Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription.

  2013cites this paper
• The DC‐HIL ligand syndecan‐4 is a negative regulator of T‐cell allo‐reactivity responsible for graft‐versus‐host disease

  2013cites this paper
• Association of cytokine/costimulatory molecule polymorphism and allograft rejection: a comparative review

  2013cites this paper
• Genomic studies of GVHD—lessons learned thus far

  2013cites this paper
• Association of the costimulatory molecule gene polymorphisms and active cytomegalovirus infection in hematopoietic stem cell transplant patients

  2013cites this paper
• The role of non-HLA gene polymorphisms in graft-versus-host disease

  2013influential citation
• Association between CTLA4 gene polymorphisms and acute rejection of kidney transplantation: a meta-analysis.

  2012cites this paper
• Evaluation of published single nucleotide polymorphisms associated with acute GVHD.

  2012cites this paper
• Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia

  2012cites this paper
• Single nucleotide polymorphisms and outcome risk in unrelated mismatched hematopoietic stem cell transplantation: an exploration study.

  2012cites this paper
• Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies.

  2012cites this paper
• CT60 single-nucleotide polymorphism as a surrogate marker for donor lymphocyte infusion outcome after allogeneic cell transplantation for acute leukemia

  2012cites this paper
• Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies

  2012cites this paper
• Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.

  2012cites this paper
• Microsatellite scanning of the immunogenome for associations with graft-versus-host disease following haematopoietic stem cell transplantation

  2012cites this paper
• after HLA-identical haematopoietic stem-cell transplantations +49 A/G*GG genotype is associated with chronic GVHD CTLA-4 Donor

  2011cites this paper
• Association of the Co-stimulatory Molecules Polymorphisms with CMV Infection in Liver Transplant Recipients

  2011cites this paper
• Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.

  2011cites this paper
• Cytotoxic T-lymphocyte antigen 4 haplotype correlates with relapse and survival after allogeneic hematopoietic SCT

  2011cites this paper
• LITHUANIAN UNIVERSITY OF HEALTH SCIENCES MEDICAL ACADEMY

  2011cites this paper
• Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial

  2010cites this paper
• Estudio de polimorfismos genéticos en la evolución clínica de pacientes sometidos a trasplante alogenico de progenitores hematopoyéticos

  2010cites this paper
• Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation

  2010cites this paper
• Allelic variants of CTLA-4 gene as important markers of immune regulation in type 1 diabetes

  2010influential citation
• CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease.

  2010cites this paper
• Immune Tolerance Induction by Integrating Innate and Adaptive Immune Regulators

  2010cites this paper
• Genetic polymorphisms in the cytokine and chemokine system: their possible importance in allogeneic stem cell transplantation.

  2010cites this paper
• CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence

  2010cites this paper
• Immunoregulatory gene polymorphisms and graft-versus-host disease

  2009cites this paper
• The CTLA4 +49 A/G polymorphism is not associated with susceptibility to type 1 diabetes mellitus in the Portuguese population

  2009cites this paper
• Genomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality.

  2009cites this paper
• Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.

  2009cites this paper
• CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy

  2009cites this paper
• New advances in hematopoietic cell transplantation

  2008cites this paper
• CT60 A/G marker of the 3'-UTR of the CTLA4 gene and liver transplant.

  2008cites this paper
• Distribution of the CTLA‐4 single nucleotide polymorphisms CT60G>A and +49A>G in psoriasis vulgaris patients and control individuals from a Polish Caucasian population

  2007cites this paper
• Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation

  2007cites this paper
• Donor CTLA-4 +49 A/G*GG genotype is associated with chronic GVHD after HLA-identical haematopoietic stem-cell transplantations.

  2007cites this paper
• Tolerance induction Toll-like receptor signaling in transplantation

  year unknowncites this paper
• Mediterranean Journal of Hematology and Infectious Diseases What Unrelated Hematopoietic Stem Cell Transplantation in Thalassemia Taught Us about Transplant Immunogenetics

  year unknowncites this paper